Dodge & Cox’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.5M | Hold |
|
|||||
|
2025
Q2 | $9.61M | Buy |
|
|||||
|
2025
Q1 | $10M | Sell |
|
|||||
|
2024
Q4 | $9.42M | Sell |
|
|||||
|
2024
Q3 | $11.6M | Sell |
|
|||||
|
2024
Q2 | $11.7M | Sell |
|
|||||
|
2024
Q1 | $10.5M | Sell |
|
|||||
|
2023
Q4 | $10.5M | Sell |
|
|||||
|
2023
Q3 | $10.7M | Sell |
|
|||||
|
2023
Q2 | $14.1M | Sell |
|
|||||
|
2023
Q1 | $15.5M | Sell |
|
|||||
|
2022
Q4 | $20.9M | Sell |
|
|||||
|
2022
Q3 | $21.2M | Sell |
|
|||||
|
2022
Q2 | $33.2M | Sell |
|
|||||
|
2022
Q1 | $53.5M | Sell |
|
|||||
|
2021
Q4 | $47.6M | Sell |
|
|||||
|
2021
Q3 | $50.7M | Sell |
|
|||||
|
2021
Q2 | $52.4M | Sell |
|
|||||
|
2021
Q1 | $44.3M | Sell |
|
|||||
|
2020
Q4 | $166M | Sell |
|
|||||
|
2020
Q3 | $812M | Sell |
|
|||||
|
2020
Q2 | $993M | Sell |
|
|||||
|
2020
Q1 | $1.33B | Sell |
|
|||||
|
2019
Q4 | $1.92B | Sell |
|
|||||
|
2019
Q3 | $2.2B | Buy |
|
|||||
|
2019
Q2 | $2.04B | Sell |
|
|||||
|
2019
Q1 | $2B | Sell |
|
|||||
|
2018
Q4 | $1.88B | Sell |
|
|||||
|
2018
Q3 | $2.02B | Sell |
|
|||||
|
2018
Q2 | $1.85B | Sell |
|
|||||
|
2018
Q1 | $1.91B | Sell |
|
|||||
|
2017
Q4 | $1.96B | Buy |
|
|||||
|
2017
Q3 | $1.9B | Sell |
|
|||||
|
2017
Q2 | $1.93B | Sell |
|
|||||
|
2017
Q1 | $1.77B | Buy |
|
|||||
|
2016
Q4 | $1.36B | Buy |
|
|||||
|
2016
Q3 | $1.39B | Buy |
|
|||||
|
2016
Q2 | $982M | Buy |
|
|||||
|
2016
Q1 | $734M | Buy |
|
|||||
|
2015
Q4 | $400M | Buy |
|